XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Paid-in Capital
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2020   55,243        
Beginning balance at Dec. 31, 2020 $ 1,130,402 $ 5,524 $ 856,092 $ 256,701 $ (8,285) $ 20,370
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Comprehensive income 22,754     33,719   (10,965)
Stock based compensation expense 1,759   1,759      
Common stock transactions related to stock based employee benefit plans (in shares)   20        
Common stock transactions related to stock based employee benefit plans (406) $ 2     (408)  
Common stock issued for stock options (in shares)   31        
Common stock issued for stock options 840 $ 3 837      
Increase (decrease) in shares during period (in shares)   51        
Increase (decrease) in stockholders' equity during period 24,947 $ 5 2,596 33,719 (408) (10,965)
Ending balance (in shares) at Mar. 31, 2021   55,294        
Ending balance at Mar. 31, 2021 1,155,349 $ 5,529 858,688 290,420 (8,693) 9,405
Beginning balance (in shares) at Dec. 31, 2021   58,504        
Beginning balance at Dec. 31, 2021 1,310,736 $ 5,850 963,851 358,598 (10,569) (6,994)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Comprehensive income (45,452)     20,588   (66,040)
Stock based compensation expense 1,419   1,419      
Common stock transactions related to stock based employee benefit plans (in shares)   7        
Common stock transactions related to stock based employee benefit plans 106 $ 1 (5)   110  
Common stock issued for stock options (in shares)   178        
Common stock issued for stock options 3,403 $ 18 3,385      
Issuance of common stock, pursuant to acquisition (in shares)   2,550        
Issuance of common stock, pursuant to acquisitions 90,234 $ 255 89,979      
Conversion of options, pursuant to acquisitions 3,833   3,833      
Dividends on common stock (7,994)     (7,994)    
Increase (decrease) in shares during period (in shares)   2,735        
Increase (decrease) in stockholders' equity during period 45,549 $ 274 98,611 12,594 110 (66,040)
Ending balance (in shares) at Mar. 31, 2022   61,239        
Ending balance at Mar. 31, 2022 $ 1,356,285 $ 6,124 $ 1,062,462 $ 371,192 $ (10,459) $ (73,034)